These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 26703918

  • 1. Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and the risk of major adverse cardiac events in patients with diabetes and prior stroke: a nationwide study.
    Shih CJ, Chen HT, Chao PW, Kuo SC, Li SY, Yang CY, Tarng DC, Ou SM, Chen YT.
    J Hypertens; 2016 Mar; 34(3):567-74; discussion 575. PubMed ID: 26703918
    [Abstract] [Full Text] [Related]

  • 2. Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on major adverse cardiac events in patients with newly diagnosed type 2 diabetes: a nationwide study.
    Shih CJ, Chu H, Ou SM, Chen YT.
    Int J Cardiol; 2015 Nov 15; 199():283-9. PubMed ID: 26218587
    [Abstract] [Full Text] [Related]

  • 3. Incidence of and Risk Factors for Severe Adverse Events in Elderly Patients Taking Angiotensin-Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers after an Acute Myocardial Infarction.
    Fang G, Annis IE, Farley JF, Mahendraratnam N, Hickson RP, Stürmer T, Robinson JG.
    Pharmacotherapy; 2018 Jan 15; 38(1):29-41. PubMed ID: 29059475
    [Abstract] [Full Text] [Related]

  • 4. Comparative effectiveness of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in patients with type 2 diabetes and retinopathy.
    Shih CJ, Chen HT, Kuo SC, Li SY, Lai PH, Chen SC, Ou SM, Chen YT.
    CMAJ; 2016 May 17; 188(8):E148-E157. PubMed ID: 27001739
    [Abstract] [Full Text] [Related]

  • 5. Comparative Effectiveness of Combination Therapy with Statins and Angiotensin-Converting Enzyme Inhibitors versus Angiotensin II Receptor Blockers in Patients with Coronary Heart Disease: A Nationwide Population-Based Cohort Study in Korea.
    Lee J, Lee S.
    Pharmacotherapy; 2018 Nov 17; 38(11):1095-1105. PubMed ID: 30225928
    [Abstract] [Full Text] [Related]

  • 6. Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Terms of Major Cardiovascular Disease Outcomes in Elderly Patients: A Nationwide Population-Based Cohort Study.
    Chien SC, Ou SM, Shih CJ, Chao PW, Li SY, Lee YJ, Kuo SC, Wang SJ, Chen TJ, Tarng DC, Chu H, Chen YT.
    Medicine (Baltimore); 2015 Oct 17; 94(43):e1751. PubMed ID: 26512568
    [Abstract] [Full Text] [Related]

  • 7. Angiotensin receptor blockers (ARB) outperform angiotensin-converting enzyme (ACE) inhibitors on ischemic stroke prevention in patients with hypertension and diabetes - A real-world population study in Taiwan.
    Pai PY, Muo CH, Sung FC, Ho HC, Lee YT.
    Int J Cardiol; 2016 Jul 15; 215():114-9. PubMed ID: 27111172
    [Abstract] [Full Text] [Related]

  • 8. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers reduced dementia risk in patients with diabetes mellitus and hypertension.
    Kuan YC, Huang KW, Yen DJ, Hu CJ, Lin CL, Kao CH.
    Int J Cardiol; 2016 Oct 01; 220():462-6. PubMed ID: 27390970
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction.
    Evans M, Carrero JJ, Szummer K, Åkerblom A, Edfors R, Spaak J, Jacobson SH, Andell P, Lindhagen L, Jernberg T.
    J Am Coll Cardiol; 2016 Apr 12; 67(14):1687-97. PubMed ID: 27056774
    [Abstract] [Full Text] [Related]

  • 10. A comparison between angiotensin converting enzyme inhibitors and angiotensin receptor blockers on end stage renal disease and major adverse cardiovascular events in diabetic patients: a population-based dynamic cohort study in Taiwan.
    Wu LS, Chang SH, Chang GJ, Liu JR, Chan YH, Lee HF, Wen MS, Chen WJ, Yeh YH, Kuo CT, See LC.
    Cardiovasc Diabetol; 2016 Apr 02; 15():56. PubMed ID: 27039185
    [Abstract] [Full Text] [Related]

  • 11. Comparative effectiveness of angiotensin receptor blockers vs. angiotensin-converting enzyme inhibitors on cardiovascular outcomes in patients initiating peritoneal dialysis.
    Shen JI, Saxena AB, Montez-Rath ME, Leng L, Chang TI, Winkelmayer WC.
    J Nephrol; 2017 Apr 02; 30(2):281-288. PubMed ID: 27485007
    [Abstract] [Full Text] [Related]

  • 12. No increase in adverse events during aliskiren use among ontario patients receiving angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers.
    Gilbert CJ, Gomes T, Mamdani MM, Hellings C, Yao Z, Garg AX, Wald R, Harel Z, Juurlink DN.
    Can J Cardiol; 2013 May 02; 29(5):586-91. PubMed ID: 23541666
    [Abstract] [Full Text] [Related]

  • 13. Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study.
    Hsieh YC, Hung CY, Li CH, Liao YC, Huang JL, Lin CH, Wu TJ.
    Medicine (Baltimore); 2016 May 02; 95(20):e3721. PubMed ID: 27196491
    [Abstract] [Full Text] [Related]

  • 14. Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Is Associated With a Reduced Risk of Poststroke Epilepsy in Patients With Ischemic Stroke.
    Chang KC, Lin CH, Huang JA.
    J Am Heart Assoc; 2024 Sep 03; 13(17):e035438. PubMed ID: 39189618
    [Abstract] [Full Text] [Related]

  • 15. Comparative Effectiveness of Renin-Angiotensin System Inhibitors and Calcium Channel Blockers in Individuals With Advanced CKD: A Nationwide Observational Cohort Study.
    Fu EL, Clase CM, Evans M, Lindholm B, Rotmans JI, Dekker FW, van Diepen M, Carrero JJ.
    Am J Kidney Dis; 2021 May 03; 77(5):719-729.e1. PubMed ID: 33246024
    [Abstract] [Full Text] [Related]

  • 16. Comparative Effectiveness of Angiotensin II Receptor Blockers Versus Angiotensin-Converting Enzyme Inhibitors Following Contemporary Treatments in Patients with Acute Myocardial Infarction: Results from the Korean Working Group in Myocardial Infarction (KorMI) Registry.
    Song PS, Seol SH, Seo GW, Kim DK, Kim KH, Yang JH, Hahn JY, Gwon HC, Ahn Y, Jeong MH, Song YB, Kim DI, Other Korean Working Group in Myocardial Infarction Registry Investigators.
    Am J Cardiovasc Drugs; 2015 Dec 03; 15(6):439-49. PubMed ID: 26153396
    [Abstract] [Full Text] [Related]

  • 17. CAC score as a possible criterion for administration of angiotensin converting enzyme inhibitors and/or angiotensin receptor blockers: the MultiEthnic Study of Atherosclerosis.
    Darabian S, Luo Y, Homat A, Khosraviani K, Wong N, Zeb I, Nasir K, Budoff MJ.
    Coron Artery Dis; 2015 Dec 03; 26(8):678-85. PubMed ID: 26398149
    [Abstract] [Full Text] [Related]

  • 18. Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker.
    Tsai MS, Tang CH, Lin CY, Chuang PY, Chen NC, Huang CH, Chang WT, Wang TD, Yu PH, Chen WJ.
    Cardiovasc Drugs Ther; 2017 Dec 03; 31(5-6):535-543. PubMed ID: 29218625
    [Abstract] [Full Text] [Related]

  • 19. The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension.
    Her AY, Choi BG, Rha SW, Kim YH, Choi CU, Jeong MH.
    PLoS One; 2020 Dec 03; 15(11):e0242314. PubMed ID: 33253206
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans.
    Derington CG, Cohen JB, Mohanty AF, Greene TH, Cook J, Ying J, Wei G, Herrick JS, Stevens VW, Jones BE, Wang L, Zheutlin AR, South AM, Hanff TC, Smith SM, Cooper-DeHoff RM, King JB, Alexander GC, Berlowitz DR, Ahmad FS, Penrod MJ, Hess R, Conroy MB, Fang JC, Rubin MA, Beddhu S, Cheung AK, Xian W, Weintraub WS, Bress AP.
    PLoS One; 2021 Dec 03; 16(4):e0248080. PubMed ID: 33891615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.